Search
Exagen Inc
XGNAdd to Watchlist
8.620USD
+0.210+2.50%
Close 09-21 16:00（ET）
208.54MMarket Cap
LossP/E TTM
Exagen Inc (XGN) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to Exagen Inc in the past month.
Buy
2 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
9.857USD+17.21%
XGN Analyst Recommendation Trends
In the current month, XGN has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XGN average Analyst price target in the last month is 9.857.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
2
6
6
6
5
5
5
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
8
7
7
7
8
8
XGN Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
4
0
0
29
HCA Healthcare Inc
HCA
5
9
11
1
0
26
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
11
3
0
0
24
Tenet Healthcare Corp
THC
5
14
4
0
0
23
Universal Health Services Inc
UHS
2
4
15
1
0
22
Labcorp Holdings Inc
LH
7
9
4
0
0
20
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
6
12
1
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Financial Forecasting
Based on analysts' estimates, XGN EPS is projected to reach -0.181 in FY2026Q3, following reported EPS of -0.132 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.19
-0.23
-0.19
-0.18
-0.19
Actual
-0.20
-0.17
-0.13
--
--
Surprise
-4.23%
+28.73%
+30.39%
--
--
FAQs
What is Exagen Inc's expected revenue for the next quarter?
Exagen Inc's expected revenue is 18.34M.
What is Exagen Inc's price target?
Analysts forecast that Exagen Inc's price target is USD 9.86, with the highest forecast at USD 12.00 and the lowest forecast at USD 9.00.
How have Exagen IncXGN's recent earnings per share performed?
The market expectation was USD -0.13, while Exagen IncXGN's earnings per share (EPS) for the previous quarter was USD -0.17. EPS for the next quarter is expected at USD -0.18.
What is the analyst rating for Exagen Inc?
Based on the ratings of Exagen Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.